Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
This entry notes a terminated observational study at Stanford evaluating the RCHOP chemotherapy regimen with or without radiation therapy fo…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial investigating thiotepa-based conditioning for allogeneic stem-cell transplantation in lymphoid malignancies, includin…
-
CLINICAL_TRIALS research · 2016-03-30Clinical Trial Update: Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Phase 3]
This is a Phase 3 randomized trial comparing G-CSF alone versus intermediate-dose Ara-C plus G-CSF mobilization in patients with Hodgkin lym…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CD30-directed CAR-T therapy (CART30) for relapsed/refractory CD30-positive lymphomas is currently recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant [EARLY_Phase 1]
Early-phase 1 trial evaluating dose monitoring of busulfan in conditioning regimens with combination chemotherapy for Hodgkin lymphoma or No…
-
CLINICAL_TRIALS research · 2015-07-15Clinical Trial Update: Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating cytokine-induced killer (CIK) cell therapy for patients with refractory non-Hodgkin lymphoma; the study …
-
CLINICAL_TRIALS research · 2015-05-05Clinical Trial Update: ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial of ESHAP-Imatinib for refractory/relapsed Non-Hodgkin lymphoma is underway. The current status is unknown.
-
CLINICAL_TRIALS research · 2014-11-13Clinical Trial Update: PEARL Study: Improvement of Non-Hodgkin's Lymphoma Care [NA]
Clinical trial update for the PEARL study on improving care for Non-Hodgkin lymphoma. The trial status is currently unknown.
-
CLINICAL_TRIALS research · 2014-08-25Clinical Trial Update: Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma [Phase 2]
Phase 2 trial evaluating BuEAM conditioning (Busulfan, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation for non…
-
CLINICAL_TRIALS research · 2014-07-24Clinical Trial Update: S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
This clinical trial update reports a completed study examining gene analyses in tissue samples from patients with B-cell non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS research · 2014-02-07Clinical Trial Update: Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)
An observational clinical trial update studying the association between B-cell non-Hodgkin lymphomas and hepatitis C virus infection, sponso…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination of gemcitabine hydrochloride, rituximab, oxaliplatin, and lenalidomide for relapse…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial update evaluating valproic acid in patients with previously treated non-Hodgkin lymphoma, Hodgkin lymphoma, or chro…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma [Phase 3]
An update on a Phase 3 trial evaluating combination chemotherapy for children with Non-Hodgkin lymphoma, with the current status not disclos…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Beta Alethine in Treating Patients With Low-Grade Lymphoma [Phase 1, Phase 2]
This clinical trial update covers the Phase 1/Phase 2 study of Beta Alethine in patients with low-grade non-Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy, radiation therapy, and bone marrow transplantation in relapsed or refractory Non-H…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update of denileukin diftitox for non-Hodgkin lymphoma. The trial status is currently unknown.
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This document reports an ongoing Phase 1/2 clinical trial evaluating gene therapy, chemotherapy, and peripheral stem cell transplantation fo…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial update evaluating a regimen of a monoclonal antibody therapy with paclitaxel and cyclosporine in patients with recurr…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 clinical trial update evaluating a combination chemotherapy regimen for adults with newly diagnosed stage III or stage IV Non-Hodg…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
This notice describes an early-phase (Phase 1) trial evaluating a monoclonal antibody therapy for patients with recurrent acute lymphoblasti…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma [Phase 3]
This is a Phase 3 clinical trial update assessing high-dose chemotherapy with or without bone marrow transplantation for patients with inter…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating chemotherapy with or without interferon alfa in patients with low-grade Non-Hodgkin lymphoma.